Company intelligence / Profile preview

The BioAnalytics Group

East Windsor, New Jersey, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

The BioAnalytics Group is a specialized consulting and software firm that provides quantitative systems pharmacology (QSP) and pharmacokinetic/pharmacodynamic (PK/PD) modeling services to the pharmaceutical and biotechnology industries. The company focuses on using advanced mathematical modeling and simulation to improve drug discovery and development decision-making. Their expertise spans from early-stage target validation to clinical trial design and optimization. By integrating biological data with computational models, they help clients predict drug efficacy and safety profiles more accurately, ultimately reducing the risk and cost of drug development.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on The BioAnalytics Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The BioAnalytics Group.

Explore the full profile